NEW DRUG PRODUCT: S

Subscribed as: bombaymann@gmail.com | Privacy Policy | Terms & Conditions

Click here to update/complete your profile, or adjust your account settings.
To unsubscribe from the First Look newsletter, click here

© 2020 Haymarket Media, Inc. | 275 7th Ave, 10th Floor, New York, NY 10001

NEW DRUG PRODUCT: VYEPTI FEATURED Find out more about Vyepti including dosing and important safety information with our slideshow, complete drug monograph, and downloadable PDF. DRUGS IN THE PIPELINE VICTORIA Trial: Vericiguat Beneficial in Patients With High-Risk Heart Failure Dasiglucagon NDA for Severe Hypoglycemia Treatment Submitted to FDA Epidiolex Gets Priority Review for Tuberous Sclerosis Complex-Associated Seizures Zimura Gets Fast Track Status for Geographic Atrophy Secondary to Dry AMD Remestemcel-L Under Review for Steroid-Refractory Acute Graft Versus Host Disease The right dose of information. eMPR.com Featured Content Collection and Use of Real-World Data Continues to Grow Around the World CME/CE Spotlight A Multidisciplinary Approach to the Management of Psoriatic Arthritis AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists CLICK HERE FOR A FULL LIST OF COURSES CE/CME Powered By myCME